Get started

Nuwellis, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

NUWE chart

Key stats

Market capitalization
3.039MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−51.13USD
Net income
−14.525MUSD
Revenue
8.543MUSD
Shares float
1.864M
Beta
2.14

About Nuwellis, Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Nestor Jaramillo
Website
chf-solutions.com
Headquarters
Eden Prairie
Employees
70
Founded
1999
ISIN
US67113Y4052

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Ideas

$NUWE Fundamentally UndervaluedAs far as undervalued plays go, Nuwellis, Inc. (NASDAQ: NUWE) could be one of the most undervalued stocks thanks to its cash balance which dwarfs its market cap. Additionally, NUWE has an FDA-cleared device which the company realizes revenues from. With the stock trading near its all-time low, NUWE
NUWE | Shhhhh! I Need to Add | LONGNuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid o
Long
5
Nuwellis Inc can't hack it. NUWEMore drops on NUWE incoming. Fractally an evident zigzag. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotte
Nuwellis Inc 🧙Revenue for the first quarter ended March 31, 2021, was $1.9 million, an increase of 18 percent compared to the prior-year period Increased Aquadex therapy utilization amongst strategic Critical Care accounts; highest levels seen in the past five quarters Enrolled first pediatric patient into the cl
Long
Nuwellis Inc 🧙Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidne
Long
2

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers